Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Jordon M Inkol

2PUBLICATIONS

12CO-AUTHORS

Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|Oct 08, 2024

Level of Expression of MHCI-Presented Neoepitopes Influences Tumor Rejection by Neoantigen-Specific CD8+ T Cells.

Li Deng, Scott R Walsh, Andrew Nguyen

|Oct 30, 2023

Determinants for Antitumor and Protumor Effects of Programmed Cell Death.

Samuel T Workenhe, Jordon M Inkol, Michael J Westerveld

Pageof 1

Frequent Collaborators

2 joint publications

Samuel T Workenhe

2 joint publications

Michael J Westerveld

2 joint publications

Scott R Walsh

1 joint publications

Shayla G Verburg

1 joint publications

Sarah M Worfolk

1 joint publications

Kaslyn L F Kallio

1 joint publications

Li Deng

1 joint publications

Andrew Nguyen

1 joint publications

Lan Chen

1 joint publications

Nader El-Sayes

Frequent Collaborators

2 joint publications

Samuel T Workenhe

2 joint publications

Michael J Westerveld

2 joint publications

Scott R Walsh

1 joint publications

Shayla G Verburg

Top Related Videos

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8<sup>+</sup> T Cell Responses

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8<sup>+</sup> T Cell Responses

Published on : May 06, 2019

See more related videos

Top Related Videos

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8<sup>+</sup> T Cell Responses

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8<sup>+</sup> T Cell Responses

Published on : May 06, 2019

See more related videos